Despite the wealth of preclinicalevidence for the anticancer effects of PPARγ ligands in various types of cancer,thiazolidinediones appear largely ineffective as monotherapy agents fortreating advanced, disseminated stages of cancer. Here, PPARG is linked to cancer.